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Objectives: Kidney Disease Outcome Quality Initiative guidelines
recommend permanent access in dialysis patients aged 0-19 who are greater
than 20kg and unlikely to be transplanted within one year. Unfortunately,
greater than 80% of these patients currently dialyze through a permanent
catheter and are exposed to the associated risks and shortcomings. With
a clear imperative to increase the incident use of permanent access in pedi-
atric patients, our objective is to examine the long-term outcomes of pedi-
atric arteriovenous ﬁstulas (AVF).
Methods: An updated retrospective review was performed of all arte-
riovenous ﬁstulas created in a hemodialysis population aged 0-19 at a single
institution from 1999 to 2012. Data abstracted included age, weight,
etiology of renal failure, time on dialysis, central venous catheter history,
and transplantation history. Data was analyzed to determine the inﬂuence
of these variables on primary and secondary patency.
Results: A total of 101 AVF in 93 patients were performed during
the study period. Mean age was 14 years (range, 3-19 years), 65 patients
(70%) were male, and mean weight was 51kg (range, 12-131 kg). Sixty-
six patients (82%) were already on hemodialysis at the time of ﬁstula crea-
tion, with a mean length of dialysis dependence of 18 months. At the time
of surgery, 78% of patients had a previous central venous catheter, and 24%
had 2 or more catheters. 43 radiocephalic ﬁstulas, 29 brachiocephalic
ﬁstulas, 20 basilic vein transpositions, and 9 femoral vein transpositions
were performed. Mean follow-up was 2.5 years. Two-year and 4-year
primary and secondary patency rates were 83% and 92%, and 65% and
83%, respectively. Increasing age was correlated with improved primary
patency (P ¼ .02), but had no impact on secondary patency. Weight,Table.
Subject
Acute
or chronic
Type of rib resection
and reconstruction Post-op complication LOS post FRR
1 Acute FRR, infraclavicular Thrombosed axillary-subclavian vein 4
2 Acute FRR, infraclavicular, partial sternotomy,
patch venoplasty
Hemothorax post op 4
3 Acute FRR, infraclavicular, partial sternotomy
patch venoplasty
Readmission for L apical extrapleural
hematoma, chest tube insertion
2
4 Acute FRR, transaxillary Readmission for R hemothorax, pigtail
catheter
3
5 Acute FRR, infraclavicular, repair of prox subclavian
vein using patch venoplasty
Readmission after ﬁrst thrombolysis/
thrombectomy for recurrent DVT
8
6 Acute FRR, infraclavicular, repair
of subclavian vein using patch venoplasty
Subdermal hematoma, bedside drainage 2
7 Acute FRR, infraclavicular, repair of prox subclavian
vein using patch venoplasty
Intra and extrapleural hematoma post op 8
8 Acute Medial claviculectomy, subclavian vein resec-
tion, IJ turn down w anastomosis
None 7
9 Acute FRR, transaxillary None 1
10 Acute FRR infraclavicular, repair of prox subclavian
vein using patch venoplasty
None 6
11 Acute FRR, infraclavicular, repair of prox subclavian
vein using patch venoplasty
None 2
12 Chronic FRR, infraclavicular, intraop venogram None 1
13 Chronic FRR infraclavicular None 1
14 Chronic FRR, infraclavicular, repair of subclavian vein
using patch venoplasty
Readmission for chest wall hematoma, and
thrombosed subclavian vein,
GSV harvest site hematoma
3
15 Chronic FRR supraclavicular and infraclavicular None 3
16 Chronic FRR, transaxillary None 2
17 Chronic FRR transaxillary 3/31/08, venogram and
balloon angioplasty subclavian vein 5/30/
08
None 1
18 Chronic FRR transaxillary 8/4/08, venogram 8/25/
08
None 1
19 Chronic NO RIB RESECTION performed due to
negative venogram
None
20 Chronic FRR, infraclavicular, repair of prox subclavian
vein using patch venoplasty
None 3
21 Chronic FRR, infraclavicular, repair of prox subclavian
vein using patch venoplasty
None 1
22 Chronic FRR infraclavicular, axillary subclavian
replacement with interposition femoral vein
graft
Readmission for thrombosed interposition
vein graft
4etiology, catheter location and catheter history were not signiﬁcantly asso-
ciated with primary or secondary patency. Sixty-eight patients (75%)
received a renal transplant in the postoperative period, with a mean time
to transplant of 556 days.
Conclusions: Arteriovenous ﬁstula creation is indicated in the pedi-
atric hemodialysis population and provides favorable long-term patency
rates. Although time to transplant is shorter for pediatric patients, focused
efforts should be made to mirror the Fistula First success in the adult
population.
Thoracic Outlet Syndrome in High-Performance Athletes
Venita Chandra, MD, Benjamin Colvard, MD, Christine Little, Cornelius
Olcott, IV, MD, Jason T. Lee, MD. Vascular Surgery, Stanford
University Medical Center, Stanford, Calif
Objectives: Repetitive upper extremity use in high performance
athletes is associated with the development of neurogenic and vascular
TOS. Surgical therapy in appropriately selected patients can provide relief
of symptoms and protection from future disability. We sought to determine
whether athletes treated for TOS can return to their prior high performance
level.
Methods: We reviewed competitive athletes treated for venous or
neurogenic TOS from 2000-2012. Patient demographics, workup, and treat-
ment approaches were analyzed. nTOS patients were assessed with quality
of life surveys using the previously validated mini-QuickDASH (QD) scale
(0-100, 100¼worse). Return to full athletic activity was deﬁned as returning
to prior competitive high school, collegiate, or professional sports.
Results: Thirty-eight competitive athletes (mean age, 21; 45% female)
were treated during the study period; 12 baseball players, 11 swimmers, 5
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1 wrestler, and 1 diver. Twenty-ﬁve (65%) of the athletes presented with
nTOS and 13 (34%) had Paget Schroetter Syndrome (PSS). All PSS patients
underwent standard treatment of thrombolysis followed by ﬁrst rib resec-
tion. Most nTOS patients were treated according to a highly-selective algo-
rithm beginning with TOS-speciﬁc physical therapy. Based on symptom
improvement after PT, 64% of the nTOS athletes ultimately underwent ﬁrst
rib resection and brachial plexus neurolysis. Return to full competitive
athletics was achieved in 79% of all patients, including 100% of the PSS
patients and 72% of the nTOS athletes. In the nTOS cohort successfully
returning to sports, six (33%) were treated only with PT. If the athlete
underwent surgery for nTOS, 75% returned to full competitive levels.
Mean QD scores improved from pre-op (36) to post-op (12) indicating
minimal disability. Recurrence of symptoms was noted in two nTOS (8%)
and two PSS (15%) athletes.
Conclusions: Standardized treatment algorithms and aggressive TOS-
speciﬁc physical therapy are key components to minimizing disability in this
special cohort of TOS patients. The majority of athletes treated for neurogenic
and venous TOS can successfully return to competitive sports at their prior high
performance level.
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Objectives: Axillosubclavian vein thrombosis is an uncommon
presentation of thoracic outlet syndrome. Treatment varies widely and
includes ﬁrst rib resection (FRR) alone, lysis and FRR + open surgical
venous reconstruction, and FRR followed by endovascular therapy (EVT)
for residual stenosis. This study reviewed our experience with alternative
management algorithms.
Methods: We retrospectively reviewed all venous TOS (vTOS)
patients undergoing operation from 08/1995-11/2012. Charts were
reviewed and patients divided into two groups. Group I patients underwent
thrombolysis followed by FRR + open venous reconstruction. Group II
patients underwent thrombolysis and FRR, +/- subsequent EVT. Patients
were distributed evenly between acute (< 2 weeks) and chronic (> 2 weeks)
presentations.
Results: Twenty-two vTOS patients initially underwent thromboly-
sis. Mean age was 28.7 years (range, 18-55); 13 (59%) were men. Group
I (12/22 ¼ 55%) patients were treated with open venous reconstruction:
10 patch angioplasty, 1 IJ turndown, and 1 femoral vein interposition
graft. All had FRR, except one, who had medial claviculectomy. Group
II (10/22 ¼ 45 %) consisted of nine patients who underwent FRR. One
required PTA for residual stenosis post FRR; 7 had subsequent venography
showing no residual compression. One patient had no FRR as the postlysis
venogram failed to showed compression. Symptoms were relieved in 21/22(95.5%) patients. Mean follow-up was 336 days (range, 0-1153). Perioper-
ative complications occurred in 9 (75%) Group I patients, including recur-
rent thrombosis requiring EVT in 2, chest wall hematoma or hemothorax
requiring drainage in 6 and vein harvest site hematoma in 1. These compli-
cations contributed to a 33% readmission rate. Among Group II patients,
complications included recurrent thrombosis in one patient who was lost
to follow-up and readmission for hemothorax requiring drainage in
another.
Conclusions: FRR alone with EVT for residual compression and
a more aggressive approach with FRR + venous reconstruction afforded
equal symptomatic relief. Direct open venous reconstruction was associated
with longer hospital stay, higher readmission rate, and higher perioperative
complication rate than TOS decompression alone.
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Objectives: The evaluation of subclavian vein compression at the
thoracic outlet has relied on venography. The use of IVUS to assess the
subclavian vein in a three-dimensional capacity may provide a more sensitive
method to identify stenosis.
Methods: The subclavian veins of patients undergoing evaluation for
venous thoracic outlet syndrome (vTOS) were evaluated by venography and
IVUS in both the symptomatic and asymptomatic limbs. IVUS evaluation
included measurement of area (mm2) at the lateral margin of the ﬁrst rib
(S1) and at the site of maximal compression (S2). Additional IVUS
measurements included dimensions (mm): anterior-posterior (AP) and
cranial-caudal (CC) at S1 and S2. Venography evaluation included determi-
nation of CC ratio between S1 and S2. Percent stenosis of areas determined
by IVUS were calculated. The ratio of change in the AP and CC dimension
between S1 and S2 were evaluated and compared to the change of CC ratio
by venography.
Results: Twenty-seven limbs from 14 patients were evaluated by
venography and IVUS for vTOS. Nine limbs from 7 patients were found
to have venographically normal appearing veins. IVUS detected an average
area stenosis of 59% 6 14% (range, 34.2%-73.9%) in venographically normal
appearing veins. The ratio of change in AP dimension by IVUS between S1
and S2 is 2.34, while the CC dimension is 1.44. This compares to a change
in CC ratio seen on venography of 1.09.
Conclusion: IVUS is highly sensitive in identifying changes in venous
dimension and detects the presence of signiﬁcant stenosis in vengraphically
normal appearing veins at the thoracic outlet. The greatest change in venous
diameter measured by IVUS occurs in the AP plane and is not seen on
venography. This more accurate means of assessing venous compression
may be clinically signiﬁcant.
